Jupiter Neurosciences JUNS Peer Comparison

NASDAQ JUNS
$3.25 +0.16 (+5.18%)
As of: Sep 10, 2026 · 10:46 AM EDT
Peer Comparison

300 Comparable Companies

Industry Personal Care Products

Jupiter Neurosciences, Inc. (JUNS) is the 297th largest of 300 Personal Care Products companies by market capitalisation, at 1.85 Mn, behind Agape ATP Corp at 2.37 Mn. The table below compares all 300 on 8 financial metrics.

Download Data
# Ticker Company match industry_code industry_group industry_group_code Market Capitalization P/E P/S Enterprise Value
1 CL Colgate Palmolive Co primary S-11 Household and Personal Products SG-05 70.36 Bn 32.56 0.00 Mn 68.99 Bn
2 KVUE Kenvue Inc. primary S-11 Household and Personal Products SG-05 34.27 Bn 20.67 0.00 Mn 33.16 Bn
3 KMB Kimberly Clark Corp primary S-11 Household and Personal Products SG-05 32.95 Bn 18.55 0.00 Mn 31.99 Bn
4 BBWI Bath & Body Works, Inc. primary S-11 Household and Personal Products SG-05 3.76 Bn 5.68 0.00 Mn 2.97 Bn
5 PBH Prestige Consumer Healthcare Inc. primary S-11 Household and Personal Products SG-05 2.33 Bn — — 2.27 Bn
6 PRGO PERRIGO Co plc primary S-11 Household and Personal Products SG-05 1.97 Bn -1.13 0.00 Mn 1.57 Bn
7 HLF Herbalife Ltd. primary S-11 Household and Personal Products SG-05 1.27 Bn 4.98 0.00 Mn 0.90 Bn
8 EPC EDGEWELL PERSONAL CARE Co primary S-11 Household and Personal Products SG-05 1.23 Bn -17.81 0.00 Mn 0.84 Bn
9 RAJAF TFA Therapeutics, Inc. primary S-11 Household and Personal Products SG-05 1.02 Bn — 0.00 Mn 1.02 Bn
10 HNST Honest Company, Inc. primary S-11 Household and Personal Products SG-05 0.61 Bn -49.97 0.00 Mn 0.50 Bn
11 USNA Usana Health Sciences Inc primary S-11 Household and Personal Products SG-05 0.28 Bn -9.48 0.00 Mn 0.11 Bn
12 BFNH Bioforce Nanosciences Holdings, Inc. primary S-11 Household and Personal Products SG-05 0.27 Bn -2,620.00 — 0.27 Bn
13 NATR Natures Sunshine Products Inc primary S-11 Household and Personal Products SG-05 0.24 Bn 13.02 0.00 Mn 0.16 Bn
14 NAGE Niagen Bioscience, Inc. primary S-11 Household and Personal Products SG-05 0.24 Bn 15.01 0.00 Mn 0.17 Bn
15 MED Medifast Inc primary S-11 Household and Personal Products SG-05 0.13 Bn -5.21 0.00 Mn -0.04 Bn
16 FTLF Fitlife Brands, Inc. primary S-11 Household and Personal Products SG-05 0.09 Bn 14.14 0.00 Mn 0.09 Bn
17 LFVN Lifevantage Corp primary S-11 Household and Personal Products SG-05 0.08 Bn 17.13 0.00 Mn 0.07 Bn
18 GWLL Goldenwell Biotech, Inc. primary S-11 Household and Personal Products SG-05 0.07 Bn -574.97 1.26 Mn 0.07 Bn
19 CFOO China Foods Holdings Ltd. primary S-11 Household and Personal Products SG-05 0.02 Bn -75.98 0.00 Mn 0.02 Bn
20 HYEX Healthy Extracts Inc. primary S-11 Household and Personal Products SG-05 0.02 Bn -22.93 0.00 Mn 0.02 Bn
21 DSY Big Tree Cloud Holdings Ltd primary S-11 Household and Personal Products SG-05 0.02 Bn — — 0.01 Bn
22 MTEX Mannatech Inc primary S-11 Household and Personal Products SG-05 0.02 Bn -1.02 0.00 Mn 0.01 Bn
23 NHTC Natural Health Trends Corp primary S-11 Household and Personal Products SG-05 0.01 Bn -8.45 0.00 Mn 0.00 Bn
24 CABR Caring Brands, Inc. primary S-11 Household and Personal Products SG-05 0.01 Bn -1.06 — 0.01 Bn
25 BIOE Bio Essence Corp primary S-11 Household and Personal Products SG-05 0.01 Bn 6.04 0.00 Mn 0.01 Bn
26 AIXN AiXin Life International, Inc. primary S-11 Household and Personal Products SG-05 0.01 Bn -3.18 0.00 Mn 0.01 Bn
27 DQWS DSwiss Inc primary S-11 Household and Personal Products SG-05 0.01 Bn -27.32 0.00 Mn 0.01 Bn
28 LIMX Limitless X Holdings Inc. primary S-11 Household and Personal Products SG-05 0.00 Bn -0.42 0.00 Mn 0.00 Bn
29 JWEL Jowell Global Ltd. primary S-11 Household and Personal Products SG-05 0.00 Bn -0.79 0.00 Mn 0.00 Bn
30 TCRG Cannaisseur Group Inc. primary S-11 Household and Personal Products SG-05 0.00 Bn -3.37 — 0.00 Bn
31 ATPC Agape ATP Corp primary S-11 Household and Personal Products SG-05 0.00 Bn -2.04 0.00 Mn 0.00 Bn
32 JUNS Jupiter Neurosciences, Inc. primary S-11 Household and Personal Products SG-05 0.00 Bn -0.18 0.00 Mn 0.00 Bn
33 ACBM Acro Biomedical Co., Ltd. primary S-11 Household and Personal Products SG-05 0.00 Bn -20.67 — 0.00 Bn
34 HIGR Hi-Great Group Holding Co primary S-11 Household and Personal Products SG-05 0.00 Bn -13.55 0.00 Mn 0.00 Bn
35 SNYR Synergy CHC Corp. primary S-11 Household and Personal Products SG-05 0.00 Bn -0.10 0.00 Mn 0.00 Bn
36 JNJ Johnson & Johnson secondary H-01 Pharmaceuticals and Biotechnology HG-01 639.77 Bn 30.41 0.00 Mn 619.01 Bn
37 ABBV AbbVie Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 445.75 Bn 70.58 0.00 Mn 439.18 Bn
38 MRK Merck & Co., Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 356.51 Bn 112.50 0.00 Mn 349.37 Bn
39 PG PROCTER & GAMBLE Co secondary S-10 Household and Personal Products SG-05 332.34 Bn 20.59 0.00 Mn 322.40 Bn
40 AMGN Amgen Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 207.59 Bn 23.74 0.00 Mn 193.60 Bn
41 GILD Gilead Sciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 178.73 Bn -61.74 0.00 Mn 175.55 Bn
42 VRTX Vertex Pharmaceuticals Inc / Ma secondary H-02 Pharmaceuticals and Biotechnology HG-01 131.17 Bn 29.78 0.00 Mn 123.32 Bn
43 REGN Regeneron Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 81.73 Bn 18.88 0.00 Mn 73.73 Bn
44 ARGX Argenx Se secondary H-02 Pharmaceuticals and Biotechnology HG-01 61.01 Bn 35.57 0.00 Mn 55.82 Bn
45 MRNA Moderna, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 53.40 Bn -16.95 0.00 Mn 48.27 Bn
46 SNY Sanofi secondary H-01 Pharmaceuticals and Biotechnology HG-01 52.11 Bn 11.18 0.00 Mn 44.73 Bn
47 TEVA Teva Pharmaceutical Industries Ltd secondary H-04 Pharmaceuticals and Biotechnology HG-01 42.28 Bn 60.75 0.00 Mn 38.63 Bn
48 ADM Archer-Daniels-Midland Co secondary S-07 Agribusiness SG-03 42.09 Bn 23.66 0.00 Mn 32.52 Bn
49 ALNY Alnylam Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 33.49 Bn 43.23 0.00 Mn 30.18 Bn
50 BIIB Biogen Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 31.64 Bn 37.90 0.00 Mn 30.35 Bn
51 ROIV Roivant Sciences Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 29.66 Bn -19.98 0.00 Mn 29.66 Bn
52 INSM INSMED Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 27.74 Bn -31.69 0.00 Mn 26.58 Bn
53 INCY Incyte Corp secondary H-01 Pharmaceuticals and Biotechnology HG-01 24.88 Bn 15.43 0.00 Mn 20.34 Bn
54 BNTX BioNTech SE secondary H-02 Pharmaceuticals and Biotechnology HG-01 23.35 Bn -13.70 0.00 Mn 9.70 Bn
55 CHD Church & Dwight Co Inc /De/ secondary S-10 Household and Personal Products SG-05 22.28 Bn 29.92 0.00 Mn 22.03 Bn
56 VTRS Viatris Inc secondary H-04 Pharmaceuticals and Biotechnology HG-01 18.79 Bn -45.76 0.00 Mn 17.91 Bn
57 ZBH Zimmer Biomet Holdings, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 17.82 Bn 21.03 0.00 Mn 17.41 Bn
58 NBIX Neurocrine Biosciences Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 16.15 Bn 22.90 0.00 Mn 15.76 Bn
59 ASND Ascendis Pharma A/S secondary H-02 Pharmaceuticals and Biotechnology HG-01 15.81 Bn 18.23 0.00 Mn 14.86 Bn
60 MDGL Madrigal Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 15.57 Bn -48.81 0.00 Mn 14.73 Bn
61 JAZZ Jazz Pharmaceuticals plc secondary H-01 Pharmaceuticals and Biotechnology HG-01 15.13 Bn 16.07 0.00 Mn 13.51 Bn
62 BBIO BridgeBio Pharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 14.61 Bn -21.11 0.00 Mn 13.89 Bn
63 EXEL Exelixis, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 14.55 Bn 16.91 0.00 Mn 13.71 Bn
64 SMMT Summit Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 13.36 Bn — — 12.67 Bn
65 HALO Halozyme Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 12.60 Bn 30.46 0.00 Mn 12.37 Bn
66 BMRN Biomarin Pharmaceutical Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 12.49 Bn 171.13 0.00 Mn 11.61 Bn
67 ARWR Arrowhead Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 11.90 Bn -43.73 0.00 Mn 10.30 Bn
68 AAVXF Abivax S.A. secondary H-02 Pharmaceuticals and Biotechnology HG-01 10.92 Bn -25.97 — 10.92 Bn
69 AXSM Axsome Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 10.89 Bn -70.81 0.00 Mn 10.57 Bn
70 CLX Clorox Co /De/ secondary S-10 Household and Personal Products SG-05 10.87 Bn 18.09 0.00 Mn 10.73 Bn
71 APGE Apogee Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 10.18 Bn -34.62 — 9.20 Bn
72 GMED Globus Medical Inc secondary H-06 Medical Devices and Diagnostics HG-02 9.97 Bn 18.62 0.00 Mn 9.37 Bn
73 PRAX Praxis Precision Medicines, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 9.86 Bn -25.86 — 9.11 Bn
74 RDY Dr Reddys Laboratories Ltd secondary H-04 Pharmaceuticals and Biotechnology HG-01 9.75 Bn 772.92 0.00 Mn 9.58 Bn
75 PTGX Protagonist Therapeutics, Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 9.52 Bn 86.24 0.00 Mn 9.52 Bn
76 IONS Ionis Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 9.16 Bn -43.17 0.00 Mn 7.11 Bn
77 GPCR Structure Therapeutics Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 8.79 Bn -46.73 — 8.79 Bn
78 CHWY Chewy, Inc. secondary S-04 Branded Foods SG-02 8.71 Bn 34.12 0.00 Mn 8.19 Bn
79 PCVX Vaxcyte, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 8.59 Bn -8.13 — 8.59 Bn
80 IBRX ImmunityBio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 8.12 Bn -8.19 0.00 Mn 7.77 Bn
81 IMVT Immunovant, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.84 Bn -14.57 — 7.84 Bn
82 TGTX Tg Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.75 Bn 17.53 0.00 Mn 7.06 Bn
83 GIFLF Grifols SA secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.54 Bn 29.70 0.00 Mn 9.09 Bn
84 SYRE Spyre Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.44 Bn -41.56 — 7.44 Bn
85 SRRK Scholar Rock Holding Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.37 Bn -18.26 — 7.37 Bn
86 RYTM Rhythm Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.97 Bn -33.13 0.00 Mn 6.63 Bn
87 CELH Celsius Holdings, Inc. secondary S-03 Beverages SG-01 6.88 Bn 114.72 0.00 Mn 6.25 Bn
88 CGON CG Oncology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.37 Bn -28.43 0.00 Mn 6.37 Bn
89 BLRX BioLineRx Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.34 Bn -707.43 0.00 Mn 6.34 Bn
90 BLCO Bausch & Lomb Corp secondary H-06 Medical Devices and Diagnostics HG-02 6.27 Bn -38.47 0.00 Mn 5.89 Bn
91 MIRM Mirum Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.21 Bn -7.22 0.00 Mn 5.77 Bn
92 KNSA Kiniksa Pharmaceuticals International, plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.97 Bn 74.02 0.00 Mn 5.44 Bn
93 XENE Xenon Pharmaceuticals Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.84 Bn -16.10 — 5.84 Bn
94 LGND Ligand Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.80 Bn 29.42 0.00 Mn 4.44 Bn
95 COGT Cogent Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.79 Bn -15.66 — 5.79 Bn
96 ORKA Oruka Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.77 Bn — — 4.05 Bn
97 DBVT DBV Technologies S.A. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.73 Bn -32.54 0.00 Mn 5.55 Bn
98 PTCT Ptc Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.60 Bn 14.63 0.00 Mn 3.37 Bn
99 ERAS Erasca, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.21 Bn -18.15 — 5.21 Bn
100 CELC Celcuity Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.80 Bn -21.91 — 4.80 Bn
101 DNLI Denali Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.02 Bn -7.87 0.00 Mn 4.02 Bn
102 DNTH Dianthus Therapeutics, Inc. /DE/ secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.01 Bn — — 3.61 Bn
103 TLPPF Telix Pharmaceuticals Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.89 Bn -521.64 0.00 Mn 3.59 Bn
104 RLAY Relay Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.79 Bn -13.27 0.00 Mn 3.79 Bn
105 VKTX Viking Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.76 Bn -7.02 — 3.76 Bn
106 IOVA Iovance Biotherapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 3.74 Bn -17.89 0.00 Mn 3.44 Bn
107 TNGX Tango Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.59 Bn -35.05 0.00 Mn 2.57 Bn
108 AMLX Amylyx Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.57 Bn -29.40 — 3.57 Bn
109 IPAR Interparfums Inc secondary S-12 Household and Personal Products SG-05 3.56 Bn 17.33 0.00 Mn 3.34 Bn
110 IDYA IDEAYA Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.51 Bn -15.94 0.00 Mn 2.68 Bn
111 RCUS Arcus Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.43 Bn -7.46 0.00 Mn 2.73 Bn
112 ABCL AbCellera Biologics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.33 Bn -20.21 0.00 Mn 3.33 Bn
113 ARQT Arcutis Biotherapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.07 Bn 107.75 0.00 Mn 2.83 Bn
114 DYN Dyne Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.00 Bn -5.82 — 3.00 Bn
115 CLDX Celldex Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.98 Bn -9.70 0.02 Mn 2.98 Bn
116 MBX MBX Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.98 Bn -28.53 — 2.98 Bn
117 IRON Disc Medicine, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.93 Bn -14.54 — 2.93 Bn
118 IMNM Immunome Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.92 Bn -10.81 0.00 Mn 2.40 Bn
119 NRIX Nurix Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.84 Bn -8.33 0.00 Mn 2.40 Bn
120 ZLAB Zai Lab Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.71 Bn -14.38 0.00 Mn 2.00 Bn
121 WDFC Wd 40 Co secondary S-10 Household and Personal Products SG-05 2.70 Bn 30.26 0.00 Mn 2.64 Bn
122 TAK Takeda Pharmaceutical Co Ltd secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.60 Bn 4.53 0.00 Mn -3.20 Bn
123 SLS SELLAS Life Sciences Group, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.59 Bn -79.73 — 2.59 Bn
124 OCUL Ocular Therapeutix, Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.49 Bn -8.23 0.00 Mn 2.49 Bn
125 BEIGF BeOne Medicines Ltd. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.48 Bn 3.74 0.00 Mn -2.62 Bn
126 VERA Vera Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.44 Bn -6.10 — 2.44 Bn
127 SUPN Supernus Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.44 Bn -28.65 0.00 Mn 2.07 Bn
128 NKTR Nektar Therapeutics secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.41 Bn -20.29 0.00 Mn 1.73 Bn
129 XTLB Xtl Biopharmaceuticals Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.38 Bn -2,975.41 — 2.38 Bn
130 HRMY Harmony Biosciences Holdings, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.37 Bn 13.30 0.00 Mn 1.57 Bn
131 AXGN Axogen, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 2.33 Bn -157.57 0.00 Mn 2.22 Bn
132 VRDN Viridian Therapeutics, Inc.\DE secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.33 Bn -5.83 0.00 Mn 2.33 Bn
133 PHVS Pharvaris N.V. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.25 Bn -11.33 — 1.88 Bn
134 SRPT Sarepta Therapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 2.21 Bn -16.15 0.00 Mn 1.42 Bn
135 NUVB Nuvation Bio Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.20 Bn -20.34 0.00 Mn 2.20 Bn
136 URGN UroGen Pharma Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.20 Bn -35.25 0.00 Mn 2.09 Bn
137 ADMA Adma Biologics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.16 Bn 12.97 0.00 Mn 2.02 Bn
138 GMAB Genmab A/S secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.10 Bn 0.17 0.00 Mn 0.60 Bn
139 AUPH Aurinia Pharmaceuticals Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.09 Bn 6.64 0.00 Mn 1.64 Bn
140 KOD Kodiak Sciences Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.08 Bn -8.58 — 2.08 Bn
141 BCRX Biocryst Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.06 Bn -5.36 0.00 Mn 1.71 Bn
142 RAPP Rapport Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.05 Bn -14.96 0.00 Mn 2.05 Bn
143 AGIO Agios Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.02 Bn -4.90 0.00 Mn 2.02 Bn
144 ZBIO Zenas BioPharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.99 Bn -4.78 0.00 Mn 1.99 Bn
145 SPB Spectrum Brands Holdings, Inc. secondary S-04 Branded Foods SG-02 1.98 Bn 23.40 0.00 Mn 1.72 Bn
146 ZYME Zymeworks Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.97 Bn -13.12 0.00 Mn 1.70 Bn
147 STOK Stoke Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.96 Bn -9.44 0.00 Mn 1.67 Bn
148 CMPS COMPASS Pathways plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.93 Bn -4.89 — 1.93 Bn
149 BHVN Biohaven Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.90 Bn -3.23 — 1.63 Bn
150 XNCR Xencor Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.83 Bn -11.22 0.00 Mn 1.45 Bn
151 VIR Vir Biotechnology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.79 Bn -7.10 0.00 Mn 1.79 Bn
152 INBX Inhibrx Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.77 Bn -13.30 0.00 Mn 1.77 Bn
153 IMCR Immunocore Holdings plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.73 Bn -95.67 0.00 Mn 0.85 Bn
154 GLPGF Lakefront Biotherapeutics NV secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.73 Bn 0.00 0.00 Mn 1.73 Bn
155 SEPN Septerna, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.73 Bn -123.73 0.00 Mn 1.73 Bn
156 RXRX Recursion Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.71 Bn -3.29 0.00 Mn 1.16 Bn
157 SNDX Syndax Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.70 Bn -9.35 0.00 Mn 1.15 Bn
158 DMRA Damora Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.67 Bn -6.36 — 1.13 Bn
159 GHRS GH Research PLC secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.67 Bn -26.83 — 1.31 Bn
160 ATAI AtaiBeckley Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.60 Bn -10.37 0.00 Mn 1.60 Bn
161 ANAB Anaptysbio, Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.58 Bn -66.10 0.00 Mn 1.29 Bn
162 SCNI Scinai Immunotherapeutics Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.58 Bn -188.43 0.00 Mn 1.58 Bn
163 FBRX Forte Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.58 Bn -20.71 — 1.23 Bn
164 BCAX Bicara Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.57 Bn -8.49 — 1.57 Bn
165 TYRA Tyra Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.53 Bn -10.29 — 1.53 Bn
166 NVAX Novavax Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.51 Bn -6.11 0.00 Mn 0.79 Bn
167 MAZE Maze Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.49 Bn -14.10 0.00 Mn 1.49 Bn
168 AAPG Ascentage Pharma Group International secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.48 Bn -9.11 0.00 Mn 1.20 Bn
169 RARE Ultragenyx Pharmaceutical Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.46 Bn -3.16 0.00 Mn 1.17 Bn
170 GLUE Monte Rosa Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.44 Bn -9.35 0.00 Mn 0.81 Bn
171 ANRO Alto Neuroscience, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.43 Bn -17.13 — 1.43 Bn
172 SDGR Schrodinger, Inc. secondary T-27 Vertical Software TG-05 1.42 Bn -26.18 0.00 Mn 1.01 Bn
173 AVBP ArriVent BioPharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.41 Bn -8.61 — 1.41 Bn
174 NMAX Newsmax Inc. secondary C-05 Advertising and Media CG-02 1.40 Bn -17.64 0.00 Mn 1.35 Bn
175 OMER Omeros Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.35 Bn 79.11 0.00 Mn 1.35 Bn
176 SVRA Savara Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.35 Bn -9.66 — 1.35 Bn
177 REPL Replimune Group, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.34 Bn -4.52 — 1.34 Bn
178 ORIC Oric Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.34 Bn -8.54 — 1.34 Bn
179 ABSI Absci Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.34 Bn -11.05 0.00 Mn 1.14 Bn
180 CGEM Cullinan Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.29 Bn -6.29 — 1.29 Bn
181 ALMS Alumis Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.27 Bn -5.23 0.00 Mn 0.76 Bn
182 VOR Vor Biopharma Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.24 Bn -1.35 — 1.24 Bn
183 CRVS Corvus Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.20 Bn -25.11 — 0.98 Bn
184 MNKD Mannkind Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.19 Bn -27.26 0.00 Mn 1.08 Bn
185 JANX Janux Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.19 Bn -11.55 0.00 Mn 1.19 Bn
186 JBIO Jade Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.16 Bn -7.54 — 1.16 Bn
187 CLYM Climb Bio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.11 Bn -19.26 — 1.11 Bn
188 IMTX Immatics N.V. secondary H-03 Pharmaceuticals and Biotechnology HG-01 1.10 Bn -4.58 0.00 Mn 0.65 Bn
189 ABUS Arbutus Biopharma Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.01 Bn 6.65 0.00 Mn 0.92 Bn
190 MLTX MoonLake Immunotherapeutics secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.99 Bn -3.73 — 0.45 Bn
191 OKYO OKYO Pharma Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.97 Bn -118.02 — 0.97 Bn
192 WVE Wave Life Sciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.96 Bn -4.76 0.00 Mn 0.59 Bn
193 MNPR Monopar Therapeutics secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.95 Bn -68.42 — 0.90 Bn
194 GERN Geron Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.93 Bn -13.83 0.00 Mn 0.63 Bn
195 ARDX Ardelyx, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.92 Bn -16.46 0.00 Mn 0.63 Bn
196 ODD Oddity Tech Ltd secondary S-12 Household and Personal Products SG-05 0.91 Bn 12.41 0.00 Mn 0.61 Bn
197 TBPH Theravance Biopharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.88 Bn 20.81 0.00 Mn 0.49 Bn
198 RIGL Rigel Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.87 Bn 2.70 0.00 Mn 0.78 Bn
199 ANNX Annexon, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.85 Bn -4.16 — 0.85 Bn
200 STTK Shattuck Labs, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.82 Bn -15.12 0.00 Mn 0.82 Bn
201 ACRS Aclaris Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.78 Bn -9.80 0.00 Mn 0.78 Bn
202 VSTM Verastem, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.78 Bn -6.76 0.00 Mn 0.64 Bn
203 AVTX Avalo Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.78 Bn -7.76 — 0.78 Bn
204 CTMX CytomX Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.75 Bn -9.93 0.00 Mn 0.42 Bn
205 PHAR Pharming Group N.V. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.75 Bn -121.07 0.00 Mn 0.59 Bn
206 ZVRA Zevra Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.72 Bn 12.34 0.00 Mn 0.50 Bn
207 ZURA Zura Bio Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.71 Bn -6.12 — 0.71 Bn
208 AURA Aura Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.67 Bn -6.12 — 0.60 Bn
209 IRWD Ironwood Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.66 Bn 2.96 0.00 Mn 0.58 Bn
210 CRMD CorMedix Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.63 Bn 4.99 0.00 Mn 0.37 Bn
211 SLN Silence Therapeutics plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.63 Bn -16.14 0.00 Mn 0.56 Bn
212 EVOH EvoAir Holdings Inc. secondary I-14 Construction Products IG-03 0.63 Bn -56.89 0.00 Mn 0.62 Bn
213 HELE Helen Of Troy Ltd secondary D-06 Household Durables DG-02 0.63 Bn -1.52 0.00 Mn 0.60 Bn
214 ALT Altimmune, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.61 Bn -8.32 — 0.61 Bn
215 CBIO Crescent Biopharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.61 Bn -3.72 0.00 Mn 0.44 Bn
216 SGMT Sagimet Biosciences Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.60 Bn -12.52 — 0.60 Bn
217 OCS Oculis Holding AG secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.60 Bn -339,460.11 — 0.60 Bn
218 ASMB Assembly Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.59 Bn 471.72 0.00 Mn 0.27 Bn
219 BWMX Betterware De Mexico, S.A.P.I. De C.V secondary S-12 Household and Personal Products SG-05 0.58 Bn 10.22 0.00 Mn 0.55 Bn
220 VALN Valneva SE secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.57 Bn -9.74 0.00 Mn 0.43 Bn
221 ARVN Arvinas, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.57 Bn 60.76 0.00 Mn 0.00 Bn
222 CTNM Contineum Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.56 Bn -9.32 — 0.56 Bn
223 FLGT Fulgent Genetics, Inc. secondary H-17 Healthcare Providers HG-04 0.56 Bn -6.60 0.00 Mn 0.30 Bn
224 TECX Tectonic Therapeutic, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.55 Bn -6.44 — 0.55 Bn
225 OVID Ovid Therapeutics Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.53 Bn -15.26 0.00 Mn 0.41 Bn
226 OABI OmniAb, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.51 Bn -11.62 0.00 Mn 0.46 Bn
227 IMUX Immunic, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.51 Bn -4.45 — 0.51 Bn
228 PRLD Prelude Therapeutics Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.50 Bn -7.43 0.00 Mn 0.22 Bn
229 ANL Adlai Nortye Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.49 Bn -10.27 0.00 Mn 0.26 Bn
230 PRTA Prothena Corp Public Ltd Co secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.48 Bn -10.91 0.00 Mn 0.19 Bn
231 CNTN Canton Strategic Holdings, Inc. secondary T-58 Fintech TG-09 0.47 Bn -5.76 0.00 Mn 0.47 Bn
232 NEUP Neuphoria Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn -19.77 — 0.45 Bn
233 KMDA Kamada Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.46 Bn 14.92 0.00 Mn 0.39 Bn
234 PBYI Puma Biotechnology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.46 Bn 15.45 0.00 Mn 0.37 Bn
235 RLMD Relmada Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.46 Bn -7.56 — 0.46 Bn
236 BBOT BridgeBio Oncology Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.45 Bn -2.27 — 0.23 Bn
237 RZLT Rezolute, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.45 Bn -5.46 — 0.45 Bn
238 DRUG Bright Minds Biosciences Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.44 Bn -15.23 — 0.44 Bn
239 CCCC C4 Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.44 Bn -4.35 0.00 Mn 0.19 Bn
240 CYPH Cypherpunk Technologies Inc. secondary T-58 Fintech TG-09 0.42 Bn 7.05 — 0.42 Bn
241 AVIR Atea Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.42 Bn -3.07 — 0.42 Bn
242 CMPX Compass Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.40 Bn -4.89 — 0.40 Bn
243 BIOA BioAge Labs, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.40 Bn -4.24 0.00 Mn 0.40 Bn
244 ARCT Arcturus Therapeutics Holdings Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.40 Bn -4.16 0.00 Mn 0.20 Bn
245 LRMR Larimar Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.40 Bn -2.25 — 0.24 Bn
246 EVMN Evommune, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.39 Bn -4.11 0.00 Mn 0.19 Bn
247 ENTA Enanta Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.38 Bn -5.99 0.00 Mn 0.19 Bn
248 HMDCF HUTCHMED (China) Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.38 Bn — — 0.39 Bn
249 OFIX Orthofix Medical Inc. secondary H-06 Medical Devices and Diagnostics HG-02 0.36 Bn -8.32 0.00 Mn 0.26 Bn
250 OCGN Ocugen, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.36 Bn -4.39 0.00 Mn 0.26 Bn
251 EYPT EyePoint, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.36 Bn -1.16 0.00 Mn 0.18 Bn
252 DMAC DiaMedica Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.35 Bn -10.65 — 0.35 Bn
253 CATX Perspective Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.35 Bn -2.91 — 0.35 Bn
254 WHWK Whitehawk Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.33 Bn -4.19 — 0.33 Bn
255 PRE Prenetics Global Ltd secondary H-08 Medical Devices and Diagnostics HG-02 0.33 Bn -7.01 0.00 Mn 0.27 Bn
256 CLLS Cellectis S.A. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.33 Bn -7.88 0.00 Mn 0.16 Bn
257 EPRX Eupraxia Pharmaceuticals Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.33 Bn -6.50 — 0.33 Bn
258 FHTX Foghorn Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -4.89 0.00 Mn 0.25 Bn
259 ELDN Eledon Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -3.82 — 0.32 Bn
260 UPB Upstream Bio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.31 Bn -1.97 0.00 Mn 0.31 Bn
261 FIXX Q32 Bio Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.30 Bn 64.31 — 0.19 Bn
262 STRO Sutro Biopharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.30 Bn -2.64 0.00 Mn 0.14 Bn
263 EQ Equillium, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.29 Bn -16.01 — 0.29 Bn
264 AGEN Agenus Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.29 Bn 3.12 0.00 Mn 0.29 Bn
265 TRDA Entrada Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -1.71 0.00 Mn 0.28 Bn
266 ACIU AC Immune SA secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -5.12 0.00 Mn 0.28 Bn
267 TLSI TriSalus Life Sciences, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 0.28 Bn -4.72 0.00 Mn 0.23 Bn
268 SABS SAB Biotherapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -4.04 — 0.28 Bn
269 BCYC Bicycle Therapeutics Plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn -1.43 0.00 Mn 0.27 Bn
270 GALT Galectin Therapeutics Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn -9.33 — 0.26 Bn
271 MGNX Macrogenics Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn -16.02 0.00 Mn 0.14 Bn
272 ANTX AN2 Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn -7.08 — 0.26 Bn
273 AKBA Akebia Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.26 Bn -8.64 0.00 Mn 0.10 Bn
274 CAMP Camp4 Therapeutics Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -5.09 0.00 Mn 0.25 Bn
275 ALXO Alx Oncology Holdings Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -3.12 — 0.25 Bn
276 IVVD Invivyd, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -2.98 0.00 Mn 0.09 Bn
277 CYDY CytoDyn Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -7.39 — 0.25 Bn
278 AVXL Anavex Life Sciences Corp. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -17.60 — 0.13 Bn
279 NUS Nu Skin Enterprises, Inc. secondary S-12 Household and Personal Products SG-05 0.23 Bn -1.05 0.00 Mn 0.04 Bn
280 SRZN Surrozen, Inc./DE secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn -3.79 0.00 Mn 0.23 Bn
281 TARA Protara Therapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.23 Bn -3.28 — 0.23 Bn
282 CGEN Compugen Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn 6.52 0.00 Mn 0.14 Bn
283 ALEC Alector, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn -2.61 0.00 Mn 0.06 Bn
284 KRRO Korro Bio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -2.72 0.00 Mn 0.11 Bn
285 GLSI Greenwich LifeSciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -10.00 — 0.22 Bn
286 FTH Faeth Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -1.13 — 0.22 Bn
287 KROS Keros Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -2.45 0.00 Mn -0.04 Bn
288 NMRA Neumora Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -1.33 — 0.22 Bn
289 PYXS Pyxis Oncology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -3.27 0.00 Mn 0.18 Bn
290 PLX Protalix BioTherapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn 10.16 0.00 Mn 0.17 Bn
291 PEPG PepGen Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -2.97 — 0.21 Bn
292 TNXP Tonix Pharmaceuticals Holding Corp. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -1.31 0.00 Mn 0.21 Bn
293 PTNM Pitanium Ltd secondary S-12 Household and Personal Products SG-05 0.21 Bn -63.51 0.00 Mn -2.70 Bn
294 ARMP Armata Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -3.30 — 0.18 Bn
295 CELG-RI Bristol Myers Squibb Co secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.20 Bn 0.02 0.00 Mn -10.86 Bn
296 PRQR ProQR Therapeutics N.V. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.20 Bn -4.15 0.00 Mn 0.07 Bn
297 CHRS Coherus Oncology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.20 Bn -1.53 0.00 Mn 0.10 Bn
298 ABOS Acumen Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.20 Bn -1.92 — 0.20 Bn
299 ACOG Alpha Cognition Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.20 Bn -7.27 0.00 Mn 0.16 Bn
300 ORGO Organogenesis Holdings Inc. secondary H-06 Medical Devices and Diagnostics HG-02 0.20 Bn -1.98 0.00 Mn 0.15 Bn